COE networks currently play an important role in the delivery of care for specialized service lines, including but not limited to solid organ transplantation (SOT), hematopoietic cell transplantation (HCT) and other specialty care programs. FoCUS initiated an exploration of COE networks as a potential component of financial solutions to curative therapies including emerging cellular therapies. Here we outline the rationale for COE networks and the potential advantages and limitations for their use in the context of cellular immunotherapies for cancer.
Share the research